Overview

Preventing Depression Recurrence in Diabetes

Status:
Completed

Trial end date:
2004-10-01

Target enrollment:

Participant gender:

Summary

To study the effectiveness of sertraline (Zoloft) in treating depression in adults with diabetes. The study will also determine whether depressed diabetic patients who have successfully responded to sertraline (Zoloft) are more likely to have depression recur if the sertraline (Zoloft) is discontinued.

Phase:

Phase 4

Details

Lead Sponsor:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Treatments:

Sertraline